Codexis shares surge 35.43% intraday after Q4 2025 earnings beat, strong 2026 revenue guidance, and Merck tech transfer agreement.

jueves, 12 de marzo de 2026, 10:23 am ET1 min de lectura
CDXS--
Codexis surged 35.43% intraday, driven by Q4 2025 results exceeding expectations (revenue of $38.9M, up 81% YoY, surpassing analyst estimates of $36.82M, and net profit of $9.6M vs. a $10.4M loss in 2024), a 2026 revenue guidance of $72–76M (above market forecasts of $70.8M), and progress in core operations, including a $37.8M technology transfer agreement with Merck and advancements in RNAi applications via its ECO Synthesis platform.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios